AEON Biopharma, Inc 8-K, filed Jul 27, 2023
AEON Biopharma, Inc. (AEON)
8-K
2023-07-27
For: 2023-07-21
View Original
Added on
April 06, 2026
About this 8-K
AEON Biopharma, Inc filed this 8-K on July 27, 2023, reporting on events of July 21, 2023.
Items reported
- Item 1.01: Entered into a material agreement
- Item 2.01: Completed an acquisition or sale of assets
- Item 3.02: Unregistered sale of equity
- Item 3.03: Change to shareholders' rights
- Item 4.01: Change of auditor
- Item 5.01: Change in control
- Item 5.02: Director or officer change, or executive pay
- Item 5.03: Charter or bylaw amendment, or fiscal year change
- Item 5.05: Code of ethics change or waiver
- Item 5.06: Change in shell company status
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits